AI’s big debt load. Moving backward on defense tech. Why we need to talk about CPUs. All that and more in this week’s Prototype.
A public health expert explains the rise of cannabis use disorder, what it is, and what it means for public health
Taiwan and Egypt show how universal screening, same-visit testing, affordable antivirals, and local care can put hepatitis C elimination within reach.
A new study shows cancer genes are not destiny: genetic background can shape whether inherited cancer risk becomes disease, when it begins, and how it develops.
For four generations, Rome’s Angelini family has built a $2.5 billion operation with drugs for depression and epilepsy in Europe. Now it’s bought its way into the U.S. market.
In this week’s edition of InnovationRx, we look at Summa Health’s first tech bets, the healthcare leaders on Forbes Veteran 250 list, BioMarin’s acquisition of an early-stage bone disease therapy, and more.
The cyberattack at CareCloud resulted in one of the largest reported data breaches in the U.S. healthcare industry this year.
Full body MRIs may detect early, symptomless cancer tumors or other serious issues, but may also return benign findings that cause unecessary anxiety and intervention.
Informing consumers and promoting innovative US manufacturing is a surer and safer path to reducing America’s reliance on imported drugs of uncertain quality
Electronic health record giant Epic Systems is working with medical care providers and two of the nation’s largest health insurers to speed prior authorization reviews.